Synven Shree Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -99.01%
- Profit Growth -242.39%
- Ebitda -29.45%
- Net Worth -299.53%
- Total Assets -76.72%
About Synven Shree Life Sciences
Synven Shree Life Sciences Private Limited (SSLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2013 and has a history of 11 years and six months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Shweta Sree Life Sciences Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shweta Kulkarni and Ram Sharma serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120MH2013PTC246951
-
Company No.
246951
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2013
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Synven Shree Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Kulkarni
|
Director | 14-Aug-2013 | Current |
|
Ram Sharma
|
Director | 01-Sep-2014 | Current |
Financial Performance of Synven Shree Life Sciences.
Synven Shree Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 99.01% decrease. The company also saw a substantial fall in profitability, with a 242.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 299.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synven Shree Life Sciences?
In 2021, Synven Shree Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ace Chemistry Solutions LlpShweta Kulkarni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synven Shree Life Sciences?
Unlock and access historical data on people associated with Synven Shree Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synven Shree Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synven Shree Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
